The influence of mass of [11C]-laniquidar and [11C]-N-desmethyl-loperamide on P-glycoprotein blockage at the blood-brain barrier

被引:14
作者
Moerman, Lieselotte [1 ]
Dumolyn, Caroline [1 ]
Boon, Paul [2 ]
De Vos, Filip [1 ]
机构
[1] Univ Ghent, Lab Radiopharm, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Lab Clin & Expt Neurophysiol, Ghent, Belgium
关键词
PET tracers; Multidrug resistance; Mdrla (-/-) mice; In vivo experiments; P-gp inhibitors; P-gp substrates; MULTIDRUG-RESISTANCE; TRANSPORTERS; INHIBITORS; EFFLUX; DRUGS; RADIOSYNTHESIS; RADIOLIGAND; MICE; PET;
D O I
10.1016/j.nucmedbio.2011.06.009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: An earlier report suggested that mass amount of PET tracers could be an important factor in brain uptake mediated by P-glycoprotein. Thereby, this study investigated the influence of mass dose of laniquidar, desmethyl-loperamide and loperamide on the P-glycoprotein-mediated brain uptake of respectively, [C-11]-laniquidar and [C-11]-N-desmethyl-loperamide ([C-11]-dLop). Methods: Wild-type (WT) mice were injected intravenously with solutions of 5.6 MBq [C-11]-laniquidar (either no carrier added or 60 mg/kg laniquidar added) or with 5.0-7.4 MBq [C-11]-dLop (either no carrier added or 3 mg/kg desmethyl loperamide). Mice were killed, and brain and blood were collected, weighted and counted for radioactivity. Mdrla(-/-) knockout mice were incorporated as the control group. Results: Injection of C-11-laniquidar (no carrier added) in WT mice resulted in a statistical significant lower brain uptake (0.7 +/- 0.2 %ID/g) compared to the carrier-added formulation (60 mg/kg laniquidar) (3.1 +/- 0.3 VolD/g) (P=.004), while no statistical difference could be observed between formulations of [C-11]-dLop. The [C-11]-laniquidar and [C-11]-dLop blood concentrations were not significantly different between the tested formulations in WT mice. In control animals, no effect of mass amount on brain uptake of both tracers could be demonstrated. Conclusions: These results demonstrate the bivalent character of laniquidar, acting as a substrate at low doses and as a blocking agent for P-glycoprotein transport in the brain at higher doses. In comparison, no difference was observed in [C-11]-dLop uptake between carrier- and no-carrier-added formulations, which confirms that desmethyl-loperamide is a substrate of P-glycoprotein at the blood brain barrier. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 20 条
[1]   Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice [J].
Bardelmeijer, HA ;
Ouwehand, M ;
Beijnen, JH ;
Schellens, JHM ;
van Tellingen, O .
INVESTIGATIONAL NEW DRUGS, 2004, 22 (03) :219-229
[2]   Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor [J].
Bauer, Florian ;
Kuntner, Claudia ;
Bankstahl, Jens P. ;
Wanek, Thomas ;
Bankstahl, Marion ;
Stanek, Johann ;
Mairinger, Severin ;
Doerner, Bernd ;
Loescher, Wolfgang ;
Mueller, Markus ;
Erker, Thomas ;
Langer, Oliver .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (15) :5489-5497
[3]   Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance [J].
Bradshaw, DM ;
Arceci, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3674-3690
[4]   Radiosynthesis and in vivo evaluation of [11C]-labelled pyrrole-2-carboxamide derivates as novel radioligands for PET imaging of monoamine oxidase A [J].
De Bruyne, Sylvie ;
La Regina, Giuseppe ;
Staelens, Steven ;
Wyffels, Leonie ;
Deleye, Steven ;
Silvestri, Romano ;
De Vos, Filip .
NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (04) :459-467
[5]   Multidrug resistance in cancer: Role of ATP-dependent transporters [J].
Gottesman, MM ;
Fojo, T ;
Bates, SE .
NATURE REVIEWS CANCER, 2002, 2 (01) :48-58
[6]  
Hazlehurst L., 2009, Pharmacology, P371
[7]   P-GLYCOPROTEIN IN ADULT SOLID TUMORS - EXPRESSION AND PROGNOSTIC-SIGNIFICANCE [J].
LEIGHTON, JC ;
GOLDSTEIN, LJ .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1995, 9 (02) :251-273
[8]   Role of multidrug transporters in pharmacoresistance to antiepileptic drugs [J].
Löscher, W ;
Potschka, H .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01) :7-14
[9]   Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats [J].
Luurtsema, Gert ;
Schuit, Robert C. ;
Klok, Rob P. ;
Verbeek, Joost ;
Leysen, Josee E. ;
Lammertsma, Adriaan A. ;
Windhorst, Albert D. .
NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (06) :643-649
[10]   Antiepileptic drugs modulate P-glycoproteins in the brain: A mice study with 11C-desmethylloperamide [J].
Moerman, Lieselotte ;
Wyffels, Leonie ;
Slaets, Dominique ;
Raedt, Robrecht ;
Boon, Paul ;
De Vos, Filip .
EPILEPSY RESEARCH, 2011, 94 (1-2) :18-25